Navigation Links
Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
Date:10/21/2008

ls. This allows for the rapid production of a high-quality adult stem cell product with increased bio-availability that may be produced on a large scale."

Adult stem cell therapies were traditionally thought to have poor therapeutic potential because they could only be produced in limited quantities or as needed. Now adult stem cells have the potential to become standardized pre-made therapies that can be mass produced.

However, both stem cell types have challenges and technical difficulties that impede product development. Embryonic stem cells, while hailed for their promise as potential therapies, are immersed in both political and ethical controversy. In addition, some researchers have questioned the safety of embryonic stem cells in humans, while adult stem cells require a high degree of technical expertise because they are difficult to culture and lose potency over time.

"Both embryonic stem cells and adult stem cells have their own challenges that must be overcome," explains Symank. "The controversy surrounding embryonic stem cells has resulted in severe limitations in federal funding for their research, while adult stem cells are often viewed as having less therapeutic potential because they can differentiate into a limited number of cells."

New evidence suggests that adult stem cells may actually have more plasticity than once thought, and may actually derive more tissue types. In addition, new technical innovations allow for adult stem cells to be cultured in large quantities without the loss of potency. In regards to embryonic stem cells, despite the severe limitations in federal funding, support from private sources and individual states have allowed research to progress at a fast pace. However, there have been concerns over the safety of the use of embryonic stem cells in humans because of potential adverse consequences from undifferentiated cells.

"In order to ensure the safety of embryonic stem cell products in humans
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
2. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
3. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. Atrium Innovations Announces Management Changes
6. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
7. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
8. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
9. Mediatech Moves to Prince William County Innovation Park
10. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
11. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., CALGARY, Nov. 6 /PRNewswire-FirstCall/ - On...olytics" or the "Company") today announced updated...YSIN(R) in patients with sarcomas metastatic to th... Connective Tissue Oncology Society Meeting held i...The poster presentation, entitled "A Phase II Stud...
(Date:11/5/2009)..., , TRANSPORTATION -- Gone hybrid . . . , Fu...omobiles are now posted at the www.fueleconomy.go...eveloped and maintains for the U.S. Department of ...y. Nine of the top 10 vehicles on the best fuel ec... Prius (51 MPG city; 48 highway). "This list prove...
(Date:11/5/2009)..., PARSIPPANY, N.J., Nov. 5 DS...has made a manufacturing alliance with Galenix, Sa...eferred commercial scale manufacturing partner for..., DSM and Galenix will collaborate on business d... delivery technologies, based on the strength of G...
(Date:11/5/2009)..., Conference Call on Thursday, November 5, 20...d VANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGe...pany") (NASDAQ: OGXI ) today reported unaudited f...nths ended September 30, 2009 and reviewed the Com..., The following consolidated results reflect th...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...tor Agonist Approved for Use as Pharmacologic ...ng-, PALO ALTO, Calif. and DEERFIELD, Ill., April.... (Nasdaq: CVTX ) and Astellas Pharma US, Inc. to...ration (FDA) has approved,Lexiscan(TM) (regadenoso...r use as a pharmacologic stress agent in radionucl...
... Vermillion, Inc.,(Nasdaq: VRML ), a molecular di... of John F. Hamilton to its board of directors. Mr...financial officer of Depomed, Inc., a,specialty ph...years of active board-level engagement on,financia...solid experience,working with small to mid-size co...
...orporation announced today a,major new release of ...IDEAS version 3.0 incorporates greatly expanded an...s on ease of use., IDEAS 3.0 provides the user wi...proves existing features to strengthen morphologic...he user with much greater,flexibility in defining ...
Other Biology Technology:CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 2CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 3CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 4CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 5Vermillion Announces Appointment of John Hamilton to Board of Directors 2Amnis Announces Release of Powerful New Image Data Analysis Software 2
(Date:11/6/2009)... ants generally live in harmony with their arborea...run out of space in their trees of choice, the ant...e research, published in the November issue of the...hat ants bore into live trees, and it reopens a ce...s and plants. , Ants and certain species of plan...
(Date:11/5/2009)...iversity has been awarded a training grant in the ...ation under its Integrative Graduation Education a...first IGERT grant to be awarded to Kent State. The...y and Reinvestment Act of 2009, runs through 2014.... on environment aquatic resource sensing (EARS). T...
(Date:11/4/2009)... - Lowly bacteria, it turns out, hold the power to...s around the world clean up toxic waste on test si...ly RDX, were invented back in World War II and hav...ese high-energy compounds are often used to propel...of TNT. , But with increased knowledge of thei...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2Time to Get the Job Done Says Alliance President and CEO 52482 1Time to Get the Job Done Says Alliance President and CEO 52482 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 1Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 3Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 4Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 5Vi typhoid vaccine proves highly effective in young children 13160 1Vi typhoid vaccine proves highly effective in young children 13160 2Vi typhoid vaccine proves highly effective in young children 13160 3
... more than the drought cutting into their yields t...tation researchers. , Dr. Tom Allen, Experiment St...se diagnostician, saw more than 150 wheat samples ...is growing season, in addition to 400-plus samples...handle. , Ninety-five percent of these samples we...
...pain can be the key either preventing or promoting...und. , "This work provides proof in principle tha...d to block cell death in situations where this is ...mer,s or Parkinson,s patients, but to promote cell...y desirable outcome," says lead researcher Peter G...
...e added one more trick to the amazing repertoire o...cal signals to nerve cells. , Nanotubes, tiny holl...iameter of a human hair, are already famed as one ... hundred times as strong as steel and one-sixth as...pper or to substitute for silicon in semiconductor...
Other Biology News:More than drought affecting wheat yields 2Protein's role in regulating cell death sets direction for cancer research 2Nanotubes used for first time to send signals to nerve cells 2
Mounting Medium from R&D Systems
Cultrex BME with phenol red from Trevigen
Human Erythropoietin, Unconjugated from R&D Systems
Kinase Chemiluminescent Assay Kit from Upstate
Biology Products: